TSX : CRDL.TO

Cardiol Therapeutics Inc. — Earnings Estimates

$1.745 CAD

-$0.07 (-4.12%)

Volume
68.34K
Average Volume
66.99K
Market Capitalization
$201.15M
P/E Ratio
-4.46
Dividend Yield
0.00%
Price Target
Year High
$2.33
Year Low
$1.23
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.39

Annual earnings financials

CRDL.TO financial data with annual/quarterly toggle

CRDL.TO GAAP EPS - Annual & Quarterly

CRDL.TO Sales Revenue - Annual & Quarterly

CRDL.TO Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CRDL.TO Estimated and Actual Revenue by Quarter
CRDL.TO Estimated and Actual EPS by Quarter
CRDL.TO Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 0 - - - - - -
2025-09-30 0 - - - - - -
CRDL.TO Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 0 -12.47M -12.47M -12.47M - - -
2026-09-30 0 -16.89M -9.65M -12.47M - - -
2026-06-30 0 -14.57M -9.72M -11.74M - - -
2026-03-31 0 -10.9M -8.72M -9.81M - - -
2025-12-31 0 -12.5M -10.42M -11.46M - - -
2025-09-30 0 -8.84M -8.04M -8.44M - - -
CRDL.TO Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 0 - - - 1 -0.11438 -0.11438 -0.11438
2026-09-30 0 - - - 3 -0.15497 -0.08855511 -0.11438
2026-06-30 0 - - - 3 -0.13372 -0.08914451 -0.10772
2026-03-31 0 - - - 3 -0.1 -0.08 -0.09
2025-12-31 0 - - - 2 -0.12468 -0.1039 -0.11429
2025-09-30 0 - - - 2 -0.10438 -0.09488857 -0.099633